Acadia Deferred Long Term Liab from 2010 to 2024
| ACHC Stock | USD 41.28 0.25 0.61% |
Deferred Long Term Liabilities | First Reported 2011-09-30 | Previous Quarter 94.4 M | Current Value 92.8 M | Quarterly Volatility 39.2 M |
Check Acadia Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acadia Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 92.7 M, Interest Expense of 106 M or Selling General Administrative of 174.7 M, as well as many indicators such as Price To Sales Ratio of 1.56, Dividend Yield of 0.0022 or PTB Ratio of 2.5. Acadia financial statements analysis is a perfect complement when working with Acadia Healthcare Valuation or Volatility modules.
Acadia | Deferred Long Term Liab |
Latest Acadia Healthcare's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Acadia Healthcare over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Acadia Healthcare's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Acadia Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Acadia Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 54,672,027 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 74.55 | |
| Mean Deviation | 32,814,421 | |
| Median | 63,880,000 | |
| Standard Deviation | 40,757,898 | |
| Sample Variance | 1661.2T | |
| Range | 140.8M | |
| R-Value | 0.69 | |
| Mean Square Error | 933.5T | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | 6,302,245 | |
| Total Sum of Squares | 23256.9T |
Acadia Deferred Long Term Liab History
About Acadia Healthcare Financial Statements
Acadia Healthcare stakeholders use historical fundamental indicators, such as Acadia Healthcare's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Acadia Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Acadia Healthcare's assets and liabilities are reflected in the revenues and expenses on Acadia Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Acadia Healthcare. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 85.5 M | 60 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Acadia Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Acadia Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Acadia Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Acadia Healthcare Stock:Check out the analysis of Acadia Healthcare Correlation against competitors. For information on how to trade Acadia Stock refer to our How to Trade Acadia Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acadia Healthcare. If investors know Acadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acadia Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.076 | Earnings Share 3.07 | Revenue Per Share 34.13 | Quarterly Revenue Growth 0.087 | Return On Assets 0.0606 |
The market value of Acadia Healthcare is measured differently than its book value, which is the value of Acadia that is recorded on the company's balance sheet. Investors also form their own opinion of Acadia Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Acadia Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acadia Healthcare's market value can be influenced by many factors that don't directly affect Acadia Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acadia Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acadia Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acadia Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.